SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-24-020290
Filing Date
2024-05-16
Accepted
2024-05-16 17:10:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 440980
2 form424b5_001.jpg GRAPHIC 49223
  Complete submission text file 0001493152-24-020290.txt   510047
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 424B5 | Act: 33 | File No.: 333-276650 | Film No.: 24956663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)